Drugs / Curcumin-preconditioned ASCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05610878 | Nov 2020 → Dec 2025 overdue | craniofacial microsomia, neurodevelopmental disorder with progressive movement abnormalities | University of the Punjab | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Curcumin-preconditioned ASCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05610878 ↗ |